Pepdox
Studies
Peptides
Calculator
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States. | Pepdox
Home
/
Search
/
PMID 34560122
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States.
Progress in cardiovascular diseases
2021
PMID: 34560122
View on PubMed
DOI: 10.1016/j.pcad.2021.09.007
Semaglutide
Authors
Aggarwal, Rahul; Vaduganathan, Muthiah; Chiu, Nicholas; Bhatt, Deepak L